Released Nov 13, 2019, after the close
10-Q filed Nov 13, 2019, 44 days after period end · 0001558370-19-010952
Q3 2019 · 10-Q
Revenue$0.00$0.00 derived— vs Q3 2018no prior Q2 2019 on file
Net Income-$1.90M-$1.90M N/M vs Q3 2018N/M vs Q2 2019
EPS Diluted-$2.27-$2.27 N/M vs Q3 2018N/M vs Q2 2019
Operating Income-$2,348,000N/M
Operating Cash Flowderived-$2,011,000N/M
Free Cash Flowderived-$2,015,000N/M
What the release said
The release
Same quarter
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $205.00K |
| Net Income | -$1.90M | -$2.07M | -$1.86M | -$2.95M |
| EPS Diluted | -$2.27 | -$0.18 | -$0.91 | -$0.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR